METDA Clinical Research Study

The METDA Study: A Phase 2, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients with Depression. Microbial Ecosystem Therapeutics (MET-2) is a new treatment approach for repopulating the gut with healthy bacteria that has been developed as an alternative to f***l transplantation. MET-2 is a biological compound that’s comprised

of live microbes that normally reside in the human gut of a healthy individual. Microbe therapy is a new treatment method that’s currently being explored for treating mood and anxiety disorders. You may be eligible to participate in the METDA study. We are now recruiting for our study documenting the effects of microbial ecosystem therapy on symptoms of depression! If you are currently living in Kingston, Ontario, Canada or Toronto, Ontario, Canada, or know anyone that might be interested, please feel free to contact us below. There is monetary reimbursement provided for participating in this study.